Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes

NCT01978405 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury
The Changes of Plasma Creatinine
The Changes of Plasma Free Radicals
The Changes of Endothelium-dependent Arterial Dilation

Interventions

DRUG: Alpha lipoic acid

Sponsor

Xiang Guang-da